TJP Labs receives FDA acceptance for Premarket Tobacco Product Application

PICKERING —TJP Labs Inc. announced the acceptance of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its brand, L!X nicotine pouches.

Marketed by its subsidiary L!X Innovations Inc. under the name L!X nicotine pouches, the brand’s application moves forward to the next step in the PMTA review process.

“TJP Labs created L!X nicotine pouches for adult (21+) users of nicotine-containing products who cannot or choose not to discontinue nicotine use, especially those who wish to transition to non-combustible, oral-use products,” said David Richmond-Peck, CEO of TJP Labs. “The acceptance of our application by the FDA showcases our team’s dedication to providing adult users with alternatives that can potentially reduce the harm associated with traditional combustible tobacco products.”